These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 12898575)

  • 1. Association of the 480 bp DAT1 allele with methylphenidate response in a sample of Irish children with ADHD.
    Kirley A; Lowe N; Hawi Z; Mullins C; Daly G; Waldman I; McCarron M; O'Donnell D; Fitzgerald M; Gill M
    Am J Med Genet B Neuropsychiatr Genet; 2003 Aug; 121B(1):50-4. PubMed ID: 12898575
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Polymorphisms of the dopamine transporter gene: influence on response to methylphenidate in attention deficit-hyperactivity disorder.
    Roman T; Rohde LA; Hutz MH
    Am J Pharmacogenomics; 2004; 4(2):83-92. PubMed ID: 15059031
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The homozygosity for 10-repeat allele at dopamine transporter gene and dopamine transporter density in Korean children with attention deficit hyperactivity disorder: relating to treatment response to methylphenidate.
    Cheon KA; Ryu YH; Kim JW; Cho DY
    Eur Neuropsychopharmacol; 2005 Jan; 15(1):95-101. PubMed ID: 15572278
    [TBL] [Abstract][Full Text] [Related]  

  • 4. No support for association between the dopamine transporter (DAT1) gene and ADHD.
    Langley K; Turic D; Peirce TR; Mills S; Van Den Bree MB; Owen MJ; O'Donovan MC; Thapar A
    Am J Med Genet B Neuropsychiatr Genet; 2005 Nov; 139B(1):7-10. PubMed ID: 16082688
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association between dopamine transporter (DAT1) genotype, left-sided inattention, and an enhanced response to methylphenidate in attention-deficit hyperactivity disorder.
    Bellgrove MA; Hawi Z; Kirley A; Fitzgerald M; Gill M; Robertson IH
    Neuropsychopharmacology; 2005 Dec; 30(12):2290-7. PubMed ID: 16123773
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dopamine transporter genotype and methylphenidate dose response in children with ADHD.
    Stein MA; Waldman ID; Sarampote CS; Seymour KE; Robb AS; Conlon C; Kim SJ; Cook EH
    Neuropsychopharmacology; 2005 Jul; 30(7):1374-82. PubMed ID: 15827573
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Functional effects of the DAT1 polymorphism on EEG measures in ADHD.
    Loo SK; Specter E; Smolen A; Hopfer C; Teale PD; Reite ML
    J Am Acad Child Adolesc Psychiatry; 2003 Aug; 42(8):986-93. PubMed ID: 12874502
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dopamine transporter gene, response to methylphenidate and cerebral blood flow in attention-deficit/hyperactivity disorder: a pilot study.
    Rohde LA; Roman T; Szobot C; Cunha RD; Hutz MH; Biederman J
    Synapse; 2003 May; 48(2):87-9. PubMed ID: 12619042
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Haplotype study of three polymorphisms at the dopamine transporter locus confirm linkage to attention-deficit/hyperactivity disorder.
    Barr CL; Xu C; Kroft J; Feng Y; Wigg K; Zai G; Tannock R; Schachar R; Malone M; Roberts W; Nöthen MM; Grünhage F; Vandenbergh DJ; Uhl G; Sunohara G; King N; Kennedy JL
    Biol Psychiatry; 2001 Feb; 49(4):333-9. PubMed ID: 11239904
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Absence of association with DAT1 polymorphism and response to methylphenidate in a sample of adults with ADHD.
    Mick E; Biederman J; Spencer T; Faraone SV; Sklar P
    Am J Med Genet B Neuropsychiatr Genet; 2006 Dec; 141B(8):890-4. PubMed ID: 16917950
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dopamine transporter gene and response to methylphenidate in attention-deficit/hyperactivity disorder.
    Roman T; Szobot C; Martins S; Biederman J; Rohde LA; Hutz MH
    Pharmacogenetics; 2002 Aug; 12(6):497-9. PubMed ID: 12172219
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic imaging study with [Tc-
    Akay AP; Kaya GÇ; Kose S; Yazıcıoğlu ÇE; Erkuran HÖ; Güney SA; Oğuz K; Keskin D; Baykara B; Emiroğlu Nİ; Eren MŞ; Kızıldağ S; Ertay T; Özsoylu D; Miral S; Durak H; Gönül AS; Rohde LA
    Prog Neuropsychopharmacol Biol Psychiatry; 2018 Aug; 86():294-300. PubMed ID: 29684537
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Confirmation of association between attention deficit hyperactivity disorder and a dopamine transporter polymorphism.
    Gill M; Daly G; Heron S; Hawi Z; Fitzgerald M
    Mol Psychiatry; 1997 Jul; 2(4):311-3. PubMed ID: 9246671
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of the risk allele of dopamine transporter gene (DAT1*10) in Omani male children with attention-deficit hyperactivity disorder.
    Simsek M; Al-Sharbati M; Al-Adawi S; Ganguly SS; Lawatia K
    Clin Biochem; 2005 Aug; 38(8):739-42. PubMed ID: 15993876
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Response to methylphenidate is not influenced by DAT1 polymorphisms in a sample of Brazilian adult patients with ADHD.
    Contini V; Victor MM; Marques FZ; Bertuzzi GP; Salgado CA; Silva KL; Sousa NO; Grevet EH; Belmonte-de-Abreu P; Bau CH
    J Neural Transm (Vienna); 2010 Feb; 117(2):269-76. PubMed ID: 20049490
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of the dopamine transporter gene (DAT1) with poor methylphenidate response.
    Winsberg BG; Comings DE
    J Am Acad Child Adolesc Psychiatry; 1999 Dec; 38(12):1474-7. PubMed ID: 10596245
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Family-based and case-control association studies of DRD4 and DAT1 polymorphisms in Chinese attention deficit hyperactivity disorder patients suggest long repeats contribute to genetic risk for the disorder.
    Qian Q; Wang Y; Zhou R; Yang L; Faraone SV
    Am J Med Genet B Neuropsychiatr Genet; 2004 Jul; 128B(1):84-9. PubMed ID: 15211638
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Catechol-O-methyltransferase Val158Met polymorphism is associated with methylphenidate response in ADHD children.
    Kereszturi E; Tarnok Z; Bognar E; Lakatos K; Farkas L; Gadoros J; Sasvari-Szekely M; Nemoda Z
    Am J Med Genet B Neuropsychiatr Genet; 2008 Dec; 147B(8):1431-5. PubMed ID: 18214865
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacogenetic predictors of methylphenidate dose-response in attention-deficit/hyperactivity disorder.
    Froehlich TE; Epstein JN; Nick TG; Melguizo Castro MS; Stein MA; Brinkman WB; Graham AJ; Langberg JM; Kahn RS
    J Am Acad Child Adolesc Psychiatry; 2011 Nov; 50(11):1129-1139.e2. PubMed ID: 22024001
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High sibling correlation on methylphenidate response but no association with DAT1-10R homozygosity in Dutch sibpairs with ADHD.
    van der Meulen EM; Bakker SC; Pauls DL; Oteman N; Kruitwagen CL; Pearson PL; Sinke RJ; Buitelaar JK
    J Child Psychol Psychiatry; 2005 Oct; 46(10):1074-80. PubMed ID: 16178931
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.